Related Experiment Video

Updated: Jan 19, 2026

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium
10:18

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

Published on: May 6, 2018

9.7K

ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease

Dong Hun Lee1,2, Tae Min Kim3, Joo Kyung Kim1

  • 1Department of Pediatrics.

Theranostics
|September 20, 2019
PubMed

Insights

ETV2, a key transcription factor, regulates cardiovascular development and blood vessel formation. Understanding its role offers new therapeutic strategies for cardiovascular diseases.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Developmental Biology

Background:

  • Cardiovascular diseases remain a leading cause of global mortality.
  • Existing treatments necessitate novel therapeutic strategies.
  • Understanding cardiovascular system biology is crucial for developing new treatments.

Purpose of the Study:

  • To discuss mechanisms of ETV2/ER71-regulated cardiovascular lineage development.
  • To explore ETV2/ER71 functions in neovascularization and cell reprogramming.
  • To highlight the therapeutic potential of ETV2/ER71 for cardiovascular diseases.

Main Methods:

  • Literature review of ETV2/ER71 functions.
  • Analysis of ETV2/ER71's role in cardiovascular development.
  • Discussion of ETV2/ER71's involvement in angiogenesis and cell reprogramming.

Main Results:

  • ETV2 (ER71) is identified as a master regulator of cardiovascular development.
  • ETV2/ER71 plays a significant role in pathophysiological angiogenesis.
  • ETV2/ER71 is involved in endothelial cell reprogramming.

Conclusions:

  • ETV2/ER71 is a critical factor in cardiovascular lineage development.
  • ETV2/ER71's functions in neovascularization and cell reprogramming present therapeutic opportunities.
  • Targeting ETV2/ER71 may offer novel treatment strategies for cardiovascular diseases.

Keywords:
ER71/ETV2FLK1/VEGFR2angiogenesiscardiovasculardirect cell reprogramming

More Related Videos

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.6K
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

2.1K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
441
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
457
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.9K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
316